Loading viewer...
investor_presentation
Format: PDF investor_presentation
Regeneron Pharmaceuticals presents its corporate overview and pipeline developments as of November 2021. The presentation covers key marketed products including EYLEA, Dupixent, Libtayo, and Praluent, along with pipeline candidates such as REGEN-COV, fasinumab, and oncology programs. Forward-looking statements address regulatory timelines, commercialization strategies, and market opportunities across ophthalmology, immunology, and oncology.
investor_presentation
23 Pages
investor_presentation
17 Pages
Dakota Gold Corp
NexTier Oilfield Solutions Investor Update 2022
investor_presentationinvestor_presentation
28 Pages
NexTier Oilfield Solutions
investor_presentation
Conn’s